Published in Vaccine on February 09, 2006
Uptake of first two doses of human papillomavirus vaccine by adolescent schoolgirls in Manchester: prospective cohort study. BMJ (2008) 3.32
Understanding the reasons why mothers do or do not have their adolescent daughters vaccinated against human papillomavirus. Ann Epidemiol (2009) 2.46
Papanicolaou screening behavior in mothers and human papillomavirus vaccine uptake in adolescent girls. Am J Public Health (2009) 2.03
Parental intention to have daughters receive the human papillomavirus vaccine. CMAJ (2007) 1.91
Challenges of implementing human papillomavirus (HPV) vaccination policy. BMJ (2007) 1.86
Parental Knowledge, Attitudes, and Behaviours towards Human Papillomavirus Vaccination for Their Children: A Systematic Review from 2001 to 2011. Obstet Gynecol Int (2011) 1.62
Factors influencing familial decision-making regarding human papillomavirus vaccination. J Pediatr Psychol (2009) 1.45
A semi-qualitative study of attitudes to vaccinating adolescents against human papillomavirus without parental consent. BMC Public Health (2007) 1.44
Vaccinating adolescent girls against human papillomavirus-Who decides? Prev Med (2010) 1.43
A systematic review of measures used in studies of human papillomavirus (HPV) vaccine acceptability. Vaccine (2010) 1.41
Integrating clinical, community, and policy perspectives on human papillomavirus vaccination. Annu Rev Public Health (2010) 1.39
Ethnic differences in human papillomavirus awareness and vaccine acceptability. J Epidemiol Community Health (2009) 1.32
Human papillomavirus and vaccination: knowledge, attitudes, and behavioural intention in adolescents and young women in Italy. Br J Cancer (2008) 1.27
Public knowledge and attitudes towards Human Papilloma Virus (HPV) vaccination. BMC Public Health (2008) 1.27
A survey of adolescent experiences of human papillomavirus vaccination in the Manchester study. Br J Cancer (2009) 1.27
Human papilloma virus vaccine and cervical cancer screening acceptability among adults in Quebec, Canada. BMC Public Health (2007) 1.25
'A false sense of security'? Understanding the role of the HPV vaccine on future cervical screening behaviour: a qualitative study of UK parents and girls of vaccination age. J Med Screen (2011) 1.21
Parent-son decision-making about human papillomavirus vaccination: a qualitative analysis. BMC Pediatr (2012) 1.19
Parental attitudes and information needs in an adolescent HPV vaccination programme. Br J Cancer (2008) 1.15
Drivers and barriers to acceptance of human-papillomavirus vaccination among young women: a qualitative and quantitative study. BMC Public Health (2010) 1.11
HPV vaccination among ethnic minorities in the UK: knowledge, acceptability and attitudes. Br J Cancer (2011) 1.08
Human papillomavirus vaccine and behavioural disinhibition. Sex Transm Infect (2011) 1.08
Effective strategies for HPV vaccine delivery: the views of pediatricians. J Adolesc Health (2007) 1.07
HPV vaccination in the UK. BMJ (2008) 1.05
A qualitative analysis of factors influencing HPV vaccine uptake in Soweto, South Africa among adolescents and their caregivers. PLoS One (2013) 1.04
School nurses' experiences of delivering the UK HPV vaccination programme in its first year. BMC Infect Dis (2011) 1.03
Knowledge of human papillomavirus infection and its prevention among adolescents and parents in the greater Milan area, Northern Italy. BMC Public Health (2010) 1.03
Sociodemographic predictors of HPV testing and vaccination acceptability: results from a population-representative sample of British women. J Med Screen (2008) 1.02
Reasons for receiving or not receiving HPV vaccination in primary schoolgirls in Tanzania: a case control study. PLoS One (2012) 1.01
Behavioral correlates of HPV vaccine acceptability in the 2007 Health Information National Trends Survey (HINTS). Cancer Epidemiol Biomarkers Prev (2010) 0.93
Determinants of HPV vaccination intentions among Dutch girls and their mothers: a cross-sectional study. BMC Public Health (2013) 0.93
Addressing health inequalities in the delivery of the human papillomavirus vaccination programme: examining the role of the school nurse. PLoS One (2012) 0.92
Comparatively low attendance during Human Papillomavirus catch-up vaccination among teenage girls in the Netherlands: Insights from a behavioral survey among parents. BMC Public Health (2012) 0.91
HPV vaccine decision-making and acceptance: does religion play a role? J Relig Health (2013) 0.91
Examining future adolescent human papillomavirus vaccine uptake, with and without a school mandate. J Adolesc Health (2010) 0.89
Sources of HPV vaccine hesitancy in parents. Hum Vaccin Immunother (2013) 0.85
Perception of human papillomavirus infection, cervical cancer and HPV vaccination in North Indian population. PLoS One (2014) 0.83
No difference in sexual behavior of adolescent girls following Human Papilloma Virus vaccination: a case study two districts in Uganda; Nakasongola and Luwero. BMC Public Health (2014) 0.83
Human papillomavirus vaccination among adolescents in Georgia. Hum Vaccin Immunother (2015) 0.82
Assessment of parental acceptance of a potential cytomegalovirus vaccine for adolescent females. Vaccine (2010) 0.81
Teenagers' understandings of and attitudes towards vaccines and vaccine-preventable diseases: a qualitative study. Vaccine (2013) 0.80
Human Papillomavirus (HPV) Vaccination and Adolescent Girls' Knowledge and Sexuality in Western Uganda: A Comparative Cross-Sectional Study. PLoS One (2015) 0.79
Middle- and high-school health education regarding adolescent vaccines and human papillomavirus. Vaccine (2010) 0.79
English proficiency, knowledge, and receipt of HPV vaccine in Vietnamese-American women. J Community Health (2013) 0.78
Risk factors for non-initiation of the human papillomavirus vaccine among adolescent survivors of childhood cancer. Cancer Prev Res (Phila) (2013) 0.78
Medical and sociodemographic factors associated with human papillomavirus (HPV) vaccination adherence among female survivors of childhood cancer. Pediatr Blood Cancer (2015) 0.76
Prevalence and predictors of human papillomavirus (HPV) vaccination among young women surviving childhood cancer. J Cancer Surviv (2015) 0.75
Measles prevention in adolescents: lessons learnt from implementing a high school catch-up vaccination programme in New South Wales, Australia, 2014-2015. Western Pac Surveill Response J (2016) 0.75
HPV vaccine: positive insights from universal adolescent HepB vaccination. J Epidemiol Community Health (2007) 0.75
Girls' explanations for being unvaccinated or under vaccinated against human papillomavirus: a content analysis of survey responses. BMC Public Health (2015) 0.75
Nationwide Survey of Knowledge and Health Beliefs regarding Human Papillomavirus among HPV-Vaccinated Female Students in Malaysia. PLoS One (2016) 0.75
Effect of school-based human papillomavirus (hpv) vaccination on adolescent girls' knowledge and acceptability of the HPV vaccine in Ibanda District in Uganda. Afr J Reprod Health (2014) 0.75
Facilitators and barriers to the acceptance of human papillomavirus (HPV) vaccination among adolescent girls: a comparison between mothers and their adolescent daughters in Hong Kong. BMC Res Notes (2017) 0.75
Using actor-partner interdependence modeling to understand HPV vaccine acceptance. PLoS One (2017) 0.75
Uptake of first two doses of human papillomavirus vaccine by adolescent schoolgirls in Manchester: prospective cohort study. BMJ (2008) 3.32
Effects of testosterone on muscle strength, physical function, body composition, and quality of life in intermediate-frail and frail elderly men: a randomized, double-blind, placebo-controlled study. J Clin Endocrinol Metab (2010) 3.15
Dose-fractionation sensitivity of prostate cancer deduced from radiotherapy outcomes of 5,969 patients in seven international institutional datasets: α/β = 1.4 (0.9-2.2) Gy. Int J Radiat Oncol Biol Phys (2011) 2.86
Design and analysis of clinical trials with clustering effects due to treatment. Clin Trials (2005) 2.62
Vitamin D status and muscle function in post-menarchal adolescent girls. J Clin Endocrinol Metab (2008) 1.86
Female genital injuries resulting from consensual and non-consensual vaginal intercourse. Forensic Sci Int (2010) 1.85
Anti-PLA2R antibodies measured by ELISA predict long-term outcome in a prevalent population of patients with idiopathic membranous nephropathy. Kidney Int (2013) 1.84
Efficacy and safety of posaconazole for chronic pulmonary aspergillosis. Clin Infect Dis (2010) 1.83
Anti-Mullerian hormone: poor assay reproducibility in a large cohort of subjects suggests sample instability. Hum Reprod (2012) 1.78
Body mass index, hormone replacement therapy, and endometrial cancer risk: a meta-analysis. Cancer Epidemiol Biomarkers Prev (2010) 1.75
Adjuvant radiotherapy for stage I endometrial cancer: an updated Cochrane systematic review and meta-analysis. J Natl Cancer Inst (2012) 1.68
Epigenetic variability in cells of normal cytology is associated with the risk of future morphological transformation. Genome Med (2012) 1.65
Evaluation of a new binary system of grading oral epithelial dysplasia for prediction of malignant transformation. Oral Oncol (2006) 1.65
Circulating basal anti-Müllerian hormone levels as predictor of ovarian response in women undergoing ovarian stimulation for in vitro fertilization. Fertil Steril (2008) 1.64
Do the effects of testosterone on muscle strength, physical function, body composition, and quality of life persist six months after treatment in intermediate-frail and frail elderly men? J Clin Endocrinol Metab (2010) 1.54
Immunological responses in women with human papillomavirus type 16 (HPV-16)-associated anogenital intraepithelial neoplasia induced by heterologous prime-boost HPV-16 oncogene vaccination. Clin Cancer Res (2004) 1.51
Human papillomavirus and cervical cancer. Lancet (2013) 1.48
Elective single embryo transfer: guidelines for practice British Fertility Society and Association of Clinical Embryologists. Hum Fertil (Camb) (2008) 1.46
A semi-qualitative study of attitudes to vaccinating adolescents against human papillomavirus without parental consent. BMC Public Health (2007) 1.44
Informing adolescents about human papillomavirus vaccination: what will parents allow? Vaccine (2008) 1.37
The dynamics and prognostic potential of DNA methylation changes at stem cell gene loci in women's cancer. PLoS Genet (2012) 1.33
Impaired tamoxifen metabolism reduces survival in familial breast cancer patients. Clin Cancer Res (2008) 1.28
Hypoxia-inducible factor 1alpha expression as an intrinsic marker of hypoxia: correlation with tumor oxygen, pimonidazole measurements, and outcome in locally advanced carcinoma of the cervix. Clin Cancer Res (2004) 1.27
Why oral histopathology suffers inter-observer variability on grading oral epithelial dysplasia: an attempt to understand the sources of variation. Oral Oncol (2006) 1.25
Immunological and clinical responses in women with vulval intraepithelial neoplasia vaccinated with a vaccinia virus encoding human papillomavirus 16/18 oncoproteins. Cancer Res (2003) 1.24
Safety and immunogenicity of TA-HPV, a recombinant vaccinia virus expressing modified human papillomavirus (HPV)-16 and HPV-18 E6 and E7 genes, in women with progressive cervical cancer. Clin Cancer Res (2002) 1.22
Delivery of chlamydia screening to young women requesting emergency hormonal contraception at pharmacies in Manchester, UK: a prospective study. BMC Womens Health (2009) 1.21
Adjuvant radiotherapy for stage I endometrial cancer. Cochrane Database Syst Rev (2012) 1.16
Therapy of human papillomavirus-related disease. Vaccine (2012) 1.11
Valuing pharmacogenetic testing services: a comparison of patients' and health care professionals' preferences. Value Health (2011) 1.10
Body mass index does not influence post-treatment survival in early stage endometrial cancer: results from the MRC ASTEC trial. Eur J Cancer (2011) 1.10
The relationships between AMH, androgens, insulin resistance and basal ovarian follicular status in non-obese subfertile women with and without polycystic ovary syndrome. Hum Reprod (2009) 1.07
Clinical and immunologic results of a phase II trial of sequential imiquimod and photodynamic therapy for vulval intraepithelial neoplasia. Clin Cancer Res (2008) 1.05
Polymorphisms of CYP19A1 and response to aromatase inhibitors in metastatic breast cancer patients. Breast Cancer Res Treat (2012) 1.00
Single fiber reflectance spectroscopy on cervical premalignancies: the potential for reduction of the number of unnecessary biopsies. J Biomed Opt (2013) 1.00
Familial tuberculosis mimicking advanced ovarian cancer. Infect Dis Obstet Gynecol (2009) 1.00
Evaluation of a primary care musculoskeletal clinical assessment service: a preliminary study. Physiotherapy (2010) 0.99
Adjuvant (post-surgery) chemotherapy for early stage epithelial ovarian cancer. Cochrane Database Syst Rev (2012) 0.98
TGF-beta1 in chronic allograft nephropathy following renal transplantation. J Nephrol (2007) 0.97
Predictors of poor perinatal outcome following maternal perception of reduced fetal movements--a prospective cohort study. PLoS One (2012) 0.97
Sociodemographic factors predicting mother's cervical screening and daughter's HPV vaccination uptake. J Epidemiol Community Health (2014) 0.96
The school nurse, the school and HPV vaccination: a qualitative study of factors affecting HPV vaccine uptake. Vaccine (2011) 0.96
Human papillomavirus infection in women with and without cervical cancer in Tehran, Iran. Int J Cancer (2011) 0.95
A report on the current status of European research on the use of human papillomavirus testing for primary cervical cancer screening. Int J Cancer (2006) 0.95
UGT1A1*28 genotype predicts gastrointestinal toxicity in patients treated with intermediate-dose irinotecan. Pharmacogenomics (2009) 0.92
Specific HIV protease inhibitors inhibit the ability of HPV16 E6 to degrade p53 and selectively kill E6-dependent cervical carcinoma cells in vitro. Antivir Ther (2006) 0.91
The reproducibility of serum anti-Müllerian hormone in subfertile women: within and between patient variability. Fertil Steril (2010) 0.90
Breast cancer susceptibility variants alter risks in familial disease. J Med Genet (2009) 0.90
The measurement of anti-Müllerian hormone: a critical appraisal. J Clin Endocrinol Metab (2013) 0.88
Women's knowledge and attitude towards mode of delivery and frequency of cesarean section on mother's request in six public and private hospitals in Tehran, Iran, 2012. J Obstet Gynaecol Res (2014) 0.88
High-flow nasal cannulae in very preterm infants after extubation. N Engl J Med (2014) 0.87
Replication and meta-analysis of 13,000 cases defines the risk for interleukin-23 receptor and autophagy-related 16-like 1 variants in Crohn's disease. Can J Gastroenterol (2010) 0.87
Human papillomavirus type 16 E2- and L1-specific serological and T-cell responses in women with vulval intraepithelial neoplasia. J Gen Virol (2003) 0.86
Blood pressure and the cystic fibrosis gene: evidence for lower pressure rises with age in female carriers. Hypertension (2004) 0.86
Adjuvant (post-surgery) chemotherapy for early stage epithelial ovarian cancer. Cochrane Database Syst Rev (2009) 0.86
A qualitative study to assess school nurses' views on vaccinating 12-13 year old school girls against human papillomavirus without parental consent. BMC Public Health (2009) 0.86
Embryo morphology as a predictor of IVF success: an evaluation of the proposed UK ACE grading scheme for cleavage stage embryos. Hum Fertil (Camb) (2012) 0.85
Effects of testosterone on skeletal muscle architecture in intermediate-frail and frail elderly men. J Gerontol A Biol Sci Med Sci (2010) 0.85
Comparison of Pap smear, visual inspection with acetic acid, and digital cervicography as cervical screening strategies. Arch Gynecol Obstet (2010) 0.85
Survey of girls' recall of a film providing information on human papillomavirus and cervical cancer 6 months after an offer of vaccination. Vaccine (2010) 0.85
Human papillomavirus 16 E6 increases the radiosensitivity of p53-mutated cervical cancer cells, associated with up-regulation of aurora A. Int J Radiat Biol (2010) 0.85
Epidemiology of posttransplantation lymphoproliferative disorder in adult renal transplant recipients. Transplantation (2013) 0.84
Human papillomavirus in cervical screening and vaccination. Clin Sci (Lond) (2006) 0.84
A pragmatic randomized controlled trial of thiopurine methyltransferase genotyping prior to azathioprine treatment: the TARGET study. Pharmacogenomics (2011) 0.84
Mothers' screening histories influence daughters' vaccination uptake: an analysis of linked cervical screening and human papillomavirus vaccination records in the North West of England. Eur J Cancer (2013) 0.84
Association between human leukocyte antigen polymorphism and human papillomavirus 16-positive vulval intraepithelial neoplasia in British women. Cancer Res (2003) 0.84
Using Bonferroni, BIC and AIC to assess evidence for alternative biological pathways: covariate selection for the multilevel Embryo-Uterus model. BMC Med Res Methodol (2013) 0.84
Variability in anti-Müllerian hormone levels: a comment on Sowers et al., Anti-Müllerian hormone and inhibin B variability during normal menstrual cycles. Fertil Steril (2010) 0.83
Cervical regeneration after diathermy excision of cervical intraepithelial neoplasia as assessed by transvaginal sonography. Eur J Obstet Gynecol Reprod Biol (2002) 0.83
Current academic clinical trials in ovarian cancer: Gynecologic Cancer Intergroup and US National Cancer Institute Clinical Trials Planning Meeting, May 2009. Int J Gynecol Cancer (2010) 0.83
A common Asn680Ser polymorphism in the follicle-stimulating hormone receptor gene is not associated with ovarian response to gonadotropin stimulation in patients undergoing in vitro fertilization. Fertil Steril (2012) 0.83
Follicle-stimulating hormone receptor gene polymorphisms are not associated with ovarian reserve markers. Fertil Steril (2012) 0.82
Adjuvant (post-surgery) chemotherapy for early stage epithelial ovarian cancer. Cochrane Database Syst Rev (2009) 0.82
Adjuvant radiotherapy for stage I endometrial cancer. Cochrane Database Syst Rev (2012) 0.81
How should we assess the safety of IVF technologies? Reprod Biomed Online (2013) 0.81
Repeatability of visual function measures in age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol (2013) 0.80
Bone mineral density in childhood survivors of acute lymphoblastic leukemia treated without cranial irradiation. J Clin Endocrinol Metab (2004) 0.80
A randomised controlled trial comparing standard or intensive management of reduced fetal movements after 36 weeks gestation--a feasibility study. BMC Pregnancy Childbirth (2013) 0.80
Carbonic anhydrase 9 (CA9) expression in tumor cells enhances sensitivity to tirapazamine. J Cancer Res Clin Oncol (2007) 0.80
Randomized, controlled trial evaluating a baby wash product on skin barrier function in healthy, term neonates. J Obstet Gynecol Neonatal Nurs (2013) 0.79
The use of optical spectroscopy for in vivo detection of cervical pre-cancer. Lasers Med Sci (2013) 0.79
Cervarix--a bivalent L1 virus-like particle vaccine for prevention of human papillomavirus type 16- and 18-associated cervical cancer. Expert Opin Biol Ther (2007) 0.79
Maternal serum activin, inhibin, human chorionic gonadotrophin and alpha-fetoprotein as second trimester predictors of pre-eclampsia. BJOG (2003) 0.79
Longitudinal changes in plasma Transforming growth factor beta-1 and post-burn scarring in children. Burns (2009) 0.79
Corticosteroid-free Kidney Transplantation Improves Growth: 2-Year Follow-up of the TWIST Randomized Controlled Trial. Transplantation (2015) 0.79
A prospective study of anal cancer screening in HIV-positive and negative MSM. AIDS (2016) 0.78
Sexual behavior and HPV infection in British women, by postal questionnaires and telephone interviews. J Med Virol (2011) 0.78
Tumour suppressor gene methylation and cervical cell folate concentration are determinants of high-risk human papillomavirus persistence: a nested case control study. BMC Cancer (2014) 0.78
Rounding of birth weights in a neonatal intensive care unit over 20 years: an analysis of a large cohort study. BMJ Open (2013) 0.78
Adjuvant (post-surgery) chemotherapy for early stage epithelial ovarian cancer. Cochrane Database Syst Rev (2015) 0.78
Gynecologic Cancer InterGroup (GCIG) Endometrial Cancer Clinical Trials Planning Meeting: taking endometrial cancer trials into the translational era. Int J Gynecol Cancer (2013) 0.77
FSH receptor genotype does not predict metaphase-II oocyte output or fertilization rates in ICSI patients. Reprod Biomed Online (2013) 0.77
Human papillomavirus as a target for management, prevention and therapy. Int J Hyperthermia (2012) 0.77
The use of vaccines in the prevention and treatment of cervical cancer. Clin Oncol (R Coll Radiol) (2002) 0.77
The second to fourth digit ratio (2D:4D) in women with and without human papillomavirus and cervical dysplasia. Am J Hum Biol (2008) 0.77